Influence of cyclodextrins on the stability of the peptide salmon calcitonin in aqueous solution

International Journal of Pharmaceutics

Volumn 186, Issue 2, 1999, Pages 205-213

  Fridbjörg Sigurjónsdóttir, Jóhanna ^a   Loftsson, Thorsteinn ^a   Másson, Már ^a  

^a UNIVERSITY OF ICELAND   (Iceland)

Author keywords

Aggregation; Aqueous solution; Cyclodextrins; Enzymatic degradation; Salmon calcitonin; Stability

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; CHYMOTRYPSIN A; CYCLODEXTRIN; PEPTIDE DERIVATIVE; PEPTIDE HORMONE; SALCATONIN;

AQUEOUS SOLUTION; ARTICLE; DRUG DEGRADATION; DRUG STABILITY; DRUG TOLERABILITY; ENZYME DEGRADATION; PH; PRIORITY JOURNAL;

CALCITONIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLODEXTRINS; DRUG STABILITY; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HYDROGEN-ION CONCENTRATION; HYDROLYSIS; KINETICS; PROTEINS; SOLUTIONS; TRYPSIN;

EID: 0345465964     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(99)00183-0     Document Type: Article

References (32)

1. Brewster M.E., Hora M.S., Simpkins J.W., Bodor N. Use of 2-hydroxypropyl-β-cyclodextrin as a solubilizing and stabilizing exipient for protein drugs. Pharm. Res. 8:1991;792-795.
2. Burke C.J., Volkin D.B., Mach H., Middaugh C.R. Effect of polyanions on the unfolding of acidic fibroblast growth factor. Biochemistry. 32:1993;6419-6426.
3. Cholewinski M., Lückel B., Horn H. Degradation pathways, analytical characterization and formulation strategies of a peptide and protein. Calcitonin and human growth hormone in comparison. Pharm. Acta Helv. 71:1996;405-419.
4. Copp H. Remembrance: calcitonin: discovery and early development. J. Endocrine Soc. 131:1992;1007-1008.
5. Frömming K.-H., Szejtli J. Cyclodextrins in Pharmacy. 1994;Kluwer Academic Publishers, Dordrecht, The Netherlands.
6. Haeberlin B., Gengenbacher T., Meinzer A., Fricker G. Cyclodextrins-useful excipients for oral peptide administration? Int. J. Pharm. 137:1996;103-110.
7. Hardman J.G., Limbird L.E., Molinoff P.B., Ruddon R.W., Gilman A.G. Goodman and Gilman's the Pharmacological Basis of Theraputics. 1996;McGraw-Hill, New York.
8. Irie T., Uekama K. Pharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluation. J. Pharm. Sci. 86:1997;147-162.
9. Lang S.R., Staudenmann W., James P. et al. Proteolysis of human calcitonin in excised bovine nasal mucosa: elucidation of the metabolic pathway by liquid secondary ionization mass spectrometry (LSIMS) and matrix assisted laser desorption ionization mass spectrometry (MALDI). Pharm. Res. 13:1996;1679-1685.
10. Lee K.C., Lee Y.J., Song H.M., Chun C.J., Deluca P.P. Degradation of synthetic salmon calcitonin in aqueous solution. Pharm. Res. 9:1992;1521-1523.
11. Lee M.L., Chien Y.W. Degradation of calcitonins in buffered solution and various mucosal extracts. Pharm. Res. 8:1991;49.
12. Loftsson T., Brewster M.E. Cyclodextrins as pharmaceutical excipients. Pharm. Technol. Eur. 9:1997;26-34.
13. Loftsson T., Brewster M.E. Pharmaceutical applications of cyclodextrins. 1. Drug solibilization and stabilization. J. Pharm. Sci. 8:1996;1017-1025.
14. Marttin E., Verhoef J.C., Romeijn S.G., Merkus F.W.H.M. Effects of absorption enhancers on rat nasal epithelium in vivo: release of marker compounds in the nasal cavity. Pharm. Res. 12:1995;1151-1157.
15. Marttin E., Verhoef J.C., Romeijn S.G., Merkus F.W.H.M. Cyclodextrins in nasal drug delivery: trends and perspectives. Szejtli J., Szente L. Eighth International Symposium on Cyclodextrins. 1996;381-386 Kluwer Academic Publishers, Budapest, Hungary.
16. Marttin E., Verhoef J.C., Romeijn S.G., Zwart P., Merkus F.W.H.M. Acute histopahological effects of benzalkonium chloride and absorption enhancers on nasal epithelium in vivo. Int. J. Pharm. 141:1996;151-160.
17. Matsubara K., Abe K., Irie T., Uekama K. Improvement of nasal bioavailability of lutenizing hormone-releasing hormone agonist, buserelin, by cyclodextrin derivatives in rats. J. Pharm. Sci. 84:1995;1295-1300.
18. Merkus F.W.H.M., Verhoef J.C., Romejin S.G., Schipper N.G.M. Absroption enhancing effects of cyclodextrins on intranasally administered insulin in rats. Pharm. Res. 8:1991;588-592.
19. Ressing M.E., Jiskoot W., Talsma H., Ingen C.W.V., Beuvery E.C., Crommelin D.J. The influence of sucrose, dextran, and hydroxypropyl-beta-cyclodextrin as lyoprotectants for a freeze-dried mouse IgG2a monoclonal antibody (MN12). Pharm. Res. 9:1992;266-270.
20. Romeijn S.G., Verhoef J.C., Marttin E., Merkus F.W.H.F. The effect of nasal drug formulations on ciliary beating in vitro. Int. J. Pharm. 135:1996;137-145.
21. Schipper N.G., Verhoef J.C., Lannoy L.M.D. et al. Nasal administration of an ACTH(4-9) peptide analouge with dimethyl-beta-cyclodextrin as an absorption enhancer: pharmacokinetics and dynamics. Br. J. Pharmacol. 110:1993;1335-1340.
22. Schipper N.G.M., Verhoef J.C., Romeijn S.G., Merkus F.W.H.M. Methylated β-cyclodextrins are able to improve the nasal absorption of salmon calcitonin. Calcif. Tissue Int. 56:1995;280-282.
23. Shao Z., Krishnamoorthy R., Mitra A.K. Cyclodextrins as nasal absorption promoters of insulin: mechanistic evaluations. Pharm. Res. 9:1992;1157-1163.
24. Shao Z., Li Y., Chermak T., Mitra A.K. Cyclodextrins as mucosal absorption promoters of insulin. II. Effects of β-cyclodextrin derivatives on α-chymotryptic degradation and enteral absorption of insulin in rats. Pharm. Res. 11:1994;1174-1179.
25. Simpkins J.W. Solubilization of ovine growth hormone with 2-hydroxypropyl-beta-cyclodextrin. J. Parenteral Sci. Tech. 45:1991;266-269.
26. Szejtli J. Cyclodextrin Technology. 1988;Kluwer Academic Publishers, Dordrecht, The Netherlands.
27. Tokihiro, K., Irie, T., Hirayama, F. and Uekama, K., 1996. Mass spectroscopic evidence on inhibiting effect of maltosyl-β-dyclodextrin on insulin self-association. Pharm. Sci., 2, 519-522.
28. Tokihiro K., Irie T., Uekama K. Varying effects of cyclodextrin derivatives on aggregation and thermal behaviour of insulin in aqueous solution. Chem. Pharm. Bull. 45:1997;525-531.
29. Watanabe Y., Matsumoto K., Kawamoto K., Yazawa S., Matsumoto M. Enhancing effect of cyclodextrins on nasal absorption of insulin and its duration in rabbits. Chem. Pharm. Bull. 40:1992;3100-3104.
30. Watanabe Y., Matsumoto Y., Seki M., Takase M., Matsumoto M. Absorption enhancement of polypeptide drugs by cyclodextrins. I. Enhanced rectal absorption of insulin from hollow-type suppositories containing insulin and cyclodextrins in rabbits. Chem. Pharm. Bull. 40:1992;3042-3047.
31. Windisch V., Deluccia F., Duhau L. et al. Degradation pathways of salmon calcitonin in aqueous solution. J. Pharm. Sci. 86:1997;359-364.
32. Yetkin, G., Çelebi, N., Özogul, C. and Demiryürek, A.T., 1997. The effect of absorption enhancers on nasal absorption of salmon calcitonin in rabbits. The 24th International Symposium on Controlled Release of Bioactive Materials, Stockholm, Sweden, pp. 419-420.